TY - JOUR
T1 - Four Susceptibility Loci for Gallstone Disease Identified in a Meta-analysis of Genome-Wide Association Studies
AU - Joshi, Amit D
AU - Andersson, Charlotte
AU - Buch, Stephan
AU - Stender, Stefan
AU - Noordam, Raymond
AU - Weng, Lu-Chen
AU - Weeke, Peter E
AU - Auer, Paul L
AU - Boehm, Bernhard
AU - Chen, Constance
AU - Choi, Hyon
AU - Curhan, Gary
AU - Denny, Joshua C
AU - De Vivo, Immaculata
AU - Eicher, John D
AU - Ellinghaus, David
AU - Folsom, Aaron R
AU - Fuchs, Charles
AU - Gala, Manish
AU - Haessler, Jeffrey
AU - Hofman, Albert
AU - Hu, Frank
AU - Hunter, David J
AU - Janssen, Harry L A
AU - Kang, Jae H
AU - Kooperberg, Charles
AU - Kraft, Peter
AU - Kratzer, Wolfgang
AU - Lieb, Wolfgang
AU - Lutsey, Pamela L
AU - Darwish Murad, Sarwa
AU - Nordestgaard, Børge G
AU - Pasquale, Louis R
AU - Reiner, Alex P
AU - Ridker, Paul M
AU - Rimm, Eric
AU - Rose, Lynda M
AU - Shaffer, Christian M
AU - Schafmayer, Clemens
AU - Tamimi, Rulla M
AU - Uitterlinden, Andre G
AU - Völker, Uwe
AU - Völzke, Henry
AU - Wakabayashi, Yoshiyuki
AU - Wiggs, Janey L.
AU - Zhu, Jun
AU - Roden, Dan M
AU - Stricker, Bruno H Ch
AU - Tang, Weihong
AU - Teumer, Alexander
AU - Hampe, Jochen
AU - Tybjærg-Hansen, Anne
AU - Chasman, Daniel I
AU - Chan, Andrew T
AU - Johnson, Andrew D
N1 - Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.
PY - 2016/8/1
Y1 - 2016/8/1
N2 - BACKGROUND & AIMS: A genome-wide association study (GWAS) of 280 cases identified the hepatic cholesterol transporter ABCG8 as a locus associated with risk for gallstone disease, but findings have not been reported from any other GWAS of this phenotype. We performed a large-scale, meta-analysis of GWASs of individuals of European ancestry with available prior genotype data, to identify additional genetic risk factors for gallstone disease.METHODS: We obtained per-allele odds ratio (OR) and standard error estimates using age- and sex-adjusted logistic regression models within each of the 10 discovery studies (8720 cases and 55,152 controls). We performed an inverse variance weighted, fixed-effects meta-analysis of study-specific estimates to identify single-nucleotide polymorphisms that were associated independently with gallstone disease. Associations were replicated in 6489 cases and 62,797 controls.RESULTS: We observed independent associations for 2 single-nucleotide polymorphisms at the ABCG8 locus: rs11887534 (OR, 1.69; 95% confidence interval [CI], 1.54-1.86; P = 2.44 × 10(-60)) and rs4245791 (OR, 1.27; P = 1.90 × 10(-34)). We also identified and/or replicated associations for rs9843304 in TM4SF4 (OR, 1.12; 95% CI, 1.08-1.16; P = 6.09 × 10(-11)), rs2547231 in SULT2A1 (encodes a sulfoconjugation enzyme that acts on hydroxysteroids and cholesterol-derived sterol bile acids) (OR, 1.17; 95% CI, 1.12-1.21; P = 2.24 × 10(-10)), rs1260326 in glucokinase regulatory protein (OR, 1.12; 95% CI, 1.07-1.17; P = 2.55 × 10(-10)), and rs6471717 near CYP7A1 (encodes an enzyme that catalyzes conversion of cholesterol to primary bile acids) (OR, 1.11; 95% CI, 1.08-1.15; P = 8.84 × 10(-9)). Among individuals of African American and Hispanic American ancestry, rs11887534 and rs4245791 were associated positively with gallstone disease risk, whereas the association for the rs1260326 variant was inverse.CONCLUSIONS: In this large-scale GWAS of gallstone disease, we identified 4 loci in genes that have putative functions in cholesterol metabolism and transport, and sulfonylation of bile acids or hydroxysteroids.
AB - BACKGROUND & AIMS: A genome-wide association study (GWAS) of 280 cases identified the hepatic cholesterol transporter ABCG8 as a locus associated with risk for gallstone disease, but findings have not been reported from any other GWAS of this phenotype. We performed a large-scale, meta-analysis of GWASs of individuals of European ancestry with available prior genotype data, to identify additional genetic risk factors for gallstone disease.METHODS: We obtained per-allele odds ratio (OR) and standard error estimates using age- and sex-adjusted logistic regression models within each of the 10 discovery studies (8720 cases and 55,152 controls). We performed an inverse variance weighted, fixed-effects meta-analysis of study-specific estimates to identify single-nucleotide polymorphisms that were associated independently with gallstone disease. Associations were replicated in 6489 cases and 62,797 controls.RESULTS: We observed independent associations for 2 single-nucleotide polymorphisms at the ABCG8 locus: rs11887534 (OR, 1.69; 95% confidence interval [CI], 1.54-1.86; P = 2.44 × 10(-60)) and rs4245791 (OR, 1.27; P = 1.90 × 10(-34)). We also identified and/or replicated associations for rs9843304 in TM4SF4 (OR, 1.12; 95% CI, 1.08-1.16; P = 6.09 × 10(-11)), rs2547231 in SULT2A1 (encodes a sulfoconjugation enzyme that acts on hydroxysteroids and cholesterol-derived sterol bile acids) (OR, 1.17; 95% CI, 1.12-1.21; P = 2.24 × 10(-10)), rs1260326 in glucokinase regulatory protein (OR, 1.12; 95% CI, 1.07-1.17; P = 2.55 × 10(-10)), and rs6471717 near CYP7A1 (encodes an enzyme that catalyzes conversion of cholesterol to primary bile acids) (OR, 1.11; 95% CI, 1.08-1.15; P = 8.84 × 10(-9)). Among individuals of African American and Hispanic American ancestry, rs11887534 and rs4245791 were associated positively with gallstone disease risk, whereas the association for the rs1260326 variant was inverse.CONCLUSIONS: In this large-scale GWAS of gallstone disease, we identified 4 loci in genes that have putative functions in cholesterol metabolism and transport, and sulfonylation of bile acids or hydroxysteroids.
KW - Journal Article
U2 - 10.1053/j.gastro.2016.04.007
DO - 10.1053/j.gastro.2016.04.007
M3 - Journal article
C2 - 27094239
SN - 0016-5085
VL - 151
JO - Gastroenterology
JF - Gastroenterology
IS - 2
ER -